Sebia S.A.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Sebia S.A. - overview

Established

1967

Location

Evry, -, France

Primary Industry

Medical Devices & Equipment

About

Founded in 1967 and based in Lisses, France, Sebia S. A. manufactures and distributes clinical protein electrophoresis equipment and in-vitro diagnostic testing technology (reagents). In October 2025, Warburg Pincus acquired a minority stake in Sebia S.


A. from CVC Capital Partners. The deal is expected to close in Q1 of 2026, subject to regulatory approvals. The company provides clinical protein electrophoresis equipment and reagents, which is a technology used in in-vitro diagnostic testing.


The firm's systems analyze proteins to screen and monitor a variety of diseases and conditions, primarily oncology (multiple myeloma), metabolic disorders such as diabetes, hemoglobinopathy, and rare pathologies.


Current Investors

La Caisse, CVC, Tethys Invest

Primary Industry

Medical Devices & Equipment

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment

Website

www.sebia.com

Verticals

HealthTech, Manufacturing

Company Stage

Mature

Total Amount Raised

Subscriber access only

Sebia S.A. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Secondary BuyoutAnnouncedSebia S.A.-
Add-onCompleted ZEUS Scientific, Inc.-
Add-on, Trade SaleCompletedOrgentec Diagnostika GmbH-
Secondary BuyoutCompletedSebia S.A.-
Secondary BuyoutCompletedSebia S.A.-

Displaying 1 - 5 of 8

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.